Background: Nuclear factor-κB (NF-κB) and small ubiquitin-like modifier (SUMO4) are key transcription factors involved in the regulation of immune responses and apoptosis. The aim of this study is to test for the association of NF-κB and SUMO gene polymorphisms with the susceptibility and severity of psoriasis among Saudi cases.
Introduction
Psoriasis vulgaris is a common chronic inflammatory skin disease characterized by red scaly plaques with various degrees of severity.
(1) The pathogenesis of psoriasis has been speculated to be due to factors originating in the skin, immune system or in the human genome.
(2-4) The immune basis of psoriasis was manifested by the presence of the activated type 1 T cells (Th1) and their cytokines in psoriatic lesions.
(5-8) As an important transcription factor, NFκB mediates the survival response by inhibiting p53-dependent apoptosis and up-regulating antiapoptotic members of the Bcl-2 family and caspase inhibitors.
(9, 10) Thus, NFκB activation might induce resistance to apoptosis of peripheral blood mononuclear cells in patients with autoimmune diseases. (11) NF-κB was found to augment the transcription of crucial genes in the activated Th1 cells which were involved in the pathogenesis of psoriasis such as TNF-α, IL-8, IL-12 and cyclin D.
(5-8, [12] [13] [14] NF-κB designates a group of critical transcription factors, the major form of which is a heterodimer of the p50 and p65/Rel A subunits, encoded by the genes NF-κB1 and NF-κB2, respectively. (15) NFκB 1 maps to chromosome 4q23-q24 and consists of 24 exons, (16, 17) and its inhibitory gene NFκBIA (encoding for IkB) is located on chromosome 14q13 and is including six exons. (18.19) Genetic studies have identified single nucleotide polymorphisms (SNPs) in NFκB1 and NFκBIA. (20, 21) Recently, a common insertion/deletion (-94 insertion/deletion ATTG rs28362491) polymorphism in the NFκB1 promoter region and a 39 -untranslated region (39UTR) polymorphism 2758 A>G (rs696) in NFκBIA were observed to be significantly correlated with inflammatory bowel disease (22, 23) and cancers. (24, 25) On the other hand, SUMO family (SUMO1, 2, 3 and 4) was found to act as a negative regulator of NF-κB through the inhibition of IκBα degradation. (26, 27) The SNP rs237025 A>G in SUMO4 gene (methionine/valine, M55V) was shown to enhance NF-κB transcriptional activity and some its dependent genes. (28, 29) Previous studies have verified that this polymorphism was strongly associated with type1 diabetes, (30) rheumatoid arthritis (RA), (31, 32) systemic lupus erythematosus (SLE), (33) Behcet's disease (34, 35) and Vogt-KoyanagiHarada syndrome (VKH). (36) Therefore, it was also speculated to be associated with psoriasis. (37) (38) (39) (40) (41) (42) This study is aiming to test for the association between polymorphisms in NF-κB1, NFκB IA and the SUMO4 with psoriasis vulgaris susceptibility and clinical pattern among Saudi patients.
Subjects and methods
Eighty five Saudi psoriasis patients were enrolled into the study. They included 45 males and 40 females with a mean (± SD) age of onset of the disease of 23.6 (±11.4) years. Controls were in the form of 47 males and 45 females of a mean (± SD) age of 26 (±11.3) years. Cases were recruited from the Dermatology Clinic affiliated to Qassim University, Saudi Arabia. All the patients were diagnosed as typical cases of psoriasis by a consultant dermatologist. For all patients, data related to their age, sex, age of onset, family history of psoriasis, consanguinity pattern, clinical presentation in terms of the area involved and severity index (PASI) score were recorded. The controls were selected from healthy blood donors with no past or family history of immune or dermatologic disorders. The work started after obtaining an authorized approval from the local health authorities as well as an informed consent from all participants.
For all patients and controls, DNA was extracted from peripheral blood samples and purified using the MagNa Pure purification system (Roche, Berlin, Germany). For determination of the NFκB 1 promoter (rs28362491) polymorphism, the SNPcontaining fragment was amplified using the following primers: 5'-TGGGCACAAGTCGTTTATGA-3' (forward) and 59-CTGGAGCCGGTAGGGAAG-39 (reverse). C followed by 2% agarose gel electrophoresis. (43) On the other hand for characterization of the SUMO rs237025 G>A gene polymorphism was carried out through the real time PCR using a readymade light mix prepared by TibMolBiol company (Berlin, Germany). This method is actually a modification of the RFLP-PCR that was performed using primers:
and restriction enzyme MseI. (34, 36) 
Statistical analysis
All data were analyzed using SPSS version 12.0.1 software. To test for the association of the studied genetic variants and susceptibility to psoriasis, the chi-square, Fisher exact and odds ratio tests were used to compare genotype and allele frequencies of psoriasis patients and controls. Association of genetic variants to the clinical pattern and severity of psoriasis was carried out by comparing the frequency of genotypes of case-subgroups regarding their age of onset, gender, family history, clinical type and PASI score. Hardy Weinberg equilibrium was tested separately for patient and control groups comparing the observed vs. expected frequencies of genotypes. All statistical tests were two-sided, and statistical significance was considered positive at a p value <0.05.
Results
Comparing cases to controls regarding the frequencies of their NF-κ B1-94 ins/del ATTG, NF-κB1A A>G and SUMO4 G>A polymorphic variants (Table 1) Table 2 . All subgroups showed a non-significant difference (p>0.05) in their genotypic frequencies except for cases with the plaque type that showed significantly increased frequency of SUMO4 A allele carriage (GA+AA genotypes) than cases with the guttate type that showed a higher frequency of the GG genotype (p=0.02). The PASI score was also found significantly higher among cases with NF-κB1A AA genotype (p=0.00). 
Discussion
This study is an attempt to shed a light on the genetic background of psoriasis among Saudi subjects which is obviously supported by the finding of a positive consanguinity and family history of the disease among about 1/5 of patients. To the best of our knowledge, this is the first study testing for the association between polymorphisms in NF-κB1, NF-κB1A and the SUMO4 genes with psoriasis vulgaris susceptibility and clinical pattern among Saudi patients. Although statistically non-significant, cases had higher frequencies of certain genotypes compared to controls as NF-κ B1 ins/del, NF-κB1A GG and SUMO4 GG genotypes. This in fact might attract our attention to the potential effect of the relatively small sample size of the study on the power and significance of results. In this respect we would recommend undertaking another large scale study testing for these genetic polymorphisms along with their expression pattern in the psoriatic skin cells. Regarding the clinical pattern and severity of psoriasis, we have observed that NF-κB1A GG was associated with higher PASI score while SUMO4 AA+AG genotypes were more associated with the plaque type.
The majority of Saudi psoriasis cases were carriers of the insertion allele while about 15% were homozygous for the deletion allele of NF-κ B1 gene which was found to result in relatively decreased NF-κB1 transcript levels and hence decreased p50/p105 NF-κB1 protein production. (22) In this respect, we speculate that the balance between the expressions of the 3 genes might be responsible for the increased expression of NF-κB in the psoriatic lesions as was previously reported. (44) Similarly, in a study conducted among Chinese psoriatic patients Li et al., reported only a marginal association between the NF-κB1-94 ins/del ATTG Ins/Ins genotype and the increased risk of psoriasis vulgaris in the cases-subgroups of onset age <or=40, PASI >20, male patients and sporadic (non-familial) patients. (45) On the other hand, Butt et al., did not observe an association between NF-κB1-94 ins/del ATTG promoter polymorphism in patient with psoriatic arthritis (PsA) from Newfoundland. (46) Comparing the distribution of NF-κB1 -94del/ins ATTG polymorphisms among Saudi controls to the controls in other studies, we could observe some variations related to ethnicity. The frequencies of the del/del, del/ins, and ins/ins genotypes of the NF-κB1 among Saudi controls were 17.5%, 41.3% and 41.2% respectively that was somewhat similar to the frequencies among German (15.6%, 45.9%, and 38.4%, respectively); but different to the frequencies among Han Chinese (18.5%, 51.9%, and 29.6%, respectively) and other Chines (17%, 58%, and 24%, respectively). (43, 47, 48) Salim et al. have also recently reported a negative association of the allelic and genotype distribution of the NF-κB promoter polymorphism with the susceptibility, clinical pattern and laboratory features of systemic sclerosis among Brazilians. (49) However, several studies have reported that the NF-κB1 and NF-κBIA polymorphisms is related to the development of inflammatory and other diseases including ulcerative colitis, Graves' disease, and diabetes mellitus, and susceptibility to tumors including melanoma, bladder cancer and colorectal cancer in different ethnic groups. (22, (50) (51) (52) (53) (54) (45) In contrast, another study has confirmed the association between this SNP of SUMO polymorphism and psoriatic patients in USA. (41) A meta-analysis study has demonstrated the association of SUMO4 M55V polymorphism with other autoimmune and inflammatory diseases, especially in Asian population. (55) Researchers have also reported a weak association of SUMO4 with type 1 diabetes that was noted in the Caucasian populations, (56) (57) (58) while a strong association was found with type1 diabetes in Asian populations. (30, 59) An association was also reported between the SUMO4 polymorphism with RA and autoimmune thyroid disease (Graves' disease and Hashimoto disease) in the Japanese population; (31) and with BD in Chinese patients; (34) although this association was negative with SLE, (33) RA, (60) BD in Korean patients (35) and with Graves' disease (61) in English patients. Hou et al.,
have also reported a non-association of the SUMO4 polymorphisms with Vogt-Koyanagi-Harada (VKH) syndrome among Chinese Han population. (36) In conclusion, Genetic polymorphisms of SUMO4 rs237025 G>A, NF-κB1-94 ins/del ATTG and NF-κB IA (2758 A>G) were not associated with the susceptibility of psoriasis vulgaris in Saudi patients. However, they might have an association with the clinical type and severity of the disease.
